Stock screenerAll disclosures →
EDGAR →
FTLF
Conviction 11HealthcareScan · Mon, Aug 10, 2026FTLF$10.03-1.76%
ResistanceSupportVol 14Insider buyVol MA14 13.71K
May 8May 27Jun 15Jul 2Jul 22Aug 7
Price10.03
Change-1.76%
Gap-1.27%
Rel volume0.71×
Avg volume12.42K
Avg $ vol128.07K
SMA 2010.39
SMA 5010.66
SMA 20013.63
Price vs 50-5.89%
Price vs 200-26.39%
MA stackbearish
50/200 cross—
Supertrendup · 9.53
RSI (14)43
MACD hist-0.02
MACD cross—
Stoch %K / %D31 / 37
ADX (14)18
+DI / −DI13 / 17
RSI divergence—
MACD divergence—
ATR %+5.17%
ADR %4.26%
52w high20.76
52w low8.88
From 52w high-51.69%
Above 52w low+12.95%
New 52w highNo
SqueezeOff
Bollinger width19.27%
%B0.32
Donchian pos29.07%
Donchian high11.25
Donchian low9.53
AVWAP (52w high)12.69
vs AVWAP high-20.99%
AVWAP (52w low)10.35
vs AVWAP low-3.12%
OBV trendDown
Chaikin MF (20)-0.20
Today vs 20d0.71×
Avg vol (14d)13.71K
Avg vol (20d)12.42K
Avg $ vol (20d)128.07K
Market cap94.19M
RS 3m (vs SPY)-0.78%
RS 6m (vs SPY)-49.45%
RS line new highNo
Trend template0/8
Technical rank15.0
1 week+1.21%
1 month-9.64%
3 months+4.92%
6 months-35.33%
1 year-32.86%
YTD-36.36%
P/E14.89
P/B2.08
P/S4.33
P/FCF12.73
EPS0.6300
Div yield—
ROE13.94%
ROA6.07%
Debt/Eq1.02
Current1.52
EV/EBITDA12.61
Gross margin144.65%
Net margin29.09%
Rev growth11.52%
EPS growth-29.59%
Price target—
Target upside—
Analyst rating—
Institutional—
Ent. value132.22M
Revenue6.71M
Net income1.72M
Gross profit9.52M
Free cash flow7.4M
IndustryMEDICINAL CHEMICALS & BOTANICAL PRODUCTS
ExchangeNasdaq
Shares out9.39M
Employees81
ListedTue, Sep 25, 2007
Free float3.29M
Float %35.1%
Short interest76.55K
Days to cover4.2d
Short volume29.0%
Squeeze score26 / 100
Next earningsThu, Aug 13, 2026 · after (3d)
EPS forecast$0.18 · 1 est
Last EPS vs est—
Last surprise—
Setup gradeD
Conviction11 / 100
Pattern quality—
Tech rank15.0 / 100
Group rank86 / 100 · Leading
Status laneNo active setup
Setup direction—
Pattern family
Resistance12.32
Support9.83
Days since event—
Candle confirm—
News sentiment—
Financials as of Tue, Mar 31, 2026 · quarterly.
Congress activity
Disclosed STOCK Act trades in FTLF
No recent disclosed trades by Congress in FTLF. STOCK Act filings can lag the trade by up to 45 days.
Insider activity
SEC Form 4 transactions in FTLF · 6 buys
| Insider | Side | Shares | Value | Traded | Filed |
|---|---|---|---|---|---|
Hansen Ryan P. President · Performance Stock Units · 2026-05-15 | Grant | 50K | — | 2026-05-15 | 2026-05-19 |
Hansen Ryan P. President · Stock Options · 2026-05-15 | Grant | 28.5K | — | 2026-05-15 | 2026-05-19 |
Hansen Ryan P. President · Stock Options · 2026-05-15 | Grant | 46.5K | — | 2026-05-15 | 2026-05-19 |
Yakatan Seth Director · Common Stock · 2026-01-15 | Buy | 164 | $3K | 2026-01-15 | 2026-04-20 |
Lingenbrink Matthew Director · Common Stock · 2026-04-10 | Buy | 3K | $29K | 2026-04-10 | 2026-04-14 |
Dawson Grant Robert Director · Common Stock · 2026-04-10 | Buy | 3K | $30K | 2026-04-10 | 2026-04-14 |
SEC filings
EDGAR filings in FTLF · 4 recent
Get daily signals & real-time alerts.
StockSetups scans ~12,300 US stocks & ETFs after every close and sorts every long setup into four ranked lanes — each with a trade plan — plus an always-on engine firing 35+ real-time intraday alerts. Free for 14 days, cancel in one click.
Start free — 14-day full access →Educational data, not financial advice. Patterns, levels and the trade plan are algorithmic, not a recommendation to trade.